{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:54:39Z","timestamp":1785351279919,"version":"3.55.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jaci.2018.05.018","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T22:07:26Z","timestamp":1527718046000},"page":"24-31.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Biological therapies for eosinophilic gastrointestinal diseases"],"prefix":"10.1016","volume":"142","author":[{"given":"Joshua B.","family":"Wechsler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.05.018_bib1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2010.05.001","article-title":"Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial","volume":"139","author":"Dohil","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ajg.2012.443","article-title":"Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia","volume":"108","author":"Moawad","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2018.05.018_bib3","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10620-009-0859-4","article-title":"Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis","volume":"55","author":"Peterson","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2018.05.018_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/apt.13576","article-title":"A prospective open clinical trial of a proton pump inhibitor, elimination diet and\/or budesonide for eosinophilic oesophagitis","volume":"43","author":"Philpott","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaci.2018.05.018_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gie.2005.07.049","article-title":"Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate","volume":"63","author":"Remedios","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaci.2018.05.018_bib6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1053\/gast.2002.32998","article-title":"Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate","volume":"122","author":"Teitelbaum","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ajg.2016.238","article-title":"Swallowed fluticasone propionate is an effective long-term maintenance therapy for children with eosinophilic esophagitis","volume":"111","author":"Andreae","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2018.05.018_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cgh.2011.01.017","article-title":"Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis","volume":"9","author":"Straumann","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2018.05.018_bib9","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/ajg.2017.202","article-title":"Long-term treatment of eosinophilic esophagitis with swallowed topical corticosteroids: development and evaluation of a therapeutic concept","volume":"112","author":"Greuter","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2018.05.018_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpeds.2015.11.026","article-title":"Adrenal insufficiency after chronic swallowed glucocorticoid therapy for eosinophilic esophagitis","volume":"170","author":"Golekoh","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2018.05.018_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.dld.2014.11.009","article-title":"Clinical characteristics, treatment outcomes, and resource utilization in children and adults with eosinophilic gastroenteritis","volume":"47","author":"Reed","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaci.2018.05.018_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.gastro.2015.11.004","article-title":"Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis","volume":"150","author":"Safroneeva","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cgh.2017.03.016","article-title":"White paper AGA: drug development for eosinophilic esophagitis","volume":"15","author":"Hirano","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2018.05.018_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.gtc.2014.02.015","article-title":"Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis","volume":"43","author":"Hirano","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaci.2018.05.018_bib15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ajg.2009.657","article-title":"Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation","volume":"105","author":"Schoepfer","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2018.05.018_bib16","first-page":"1","article-title":"Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring","volume":"30","author":"Collins","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaci.2018.05.018_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2018.05.018_bib18","article-title":"Eosinophilic esophagitis reference score accurately identifies disease activity and treatment effects in children","author":"Wechsler","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2018.05.018_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.gastro.2016.11.021","article-title":"Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis","volume":"152","author":"Dellon","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib20","series-title":"A randomized, double-blind, placebo-controlled trial of a novel recombinant, humanized, anti-interleukin-13 monoclonal antibody (RPC4046) in patients with active eosinophilic esophagitis: results of the HEROES study. United Eur Gastroenterol Week","author":"Hirano","year":"2016"},{"key":"10.1016\/j.jaci.2018.05.018_bib21","series-title":"Dupilumab efficacy and safety in adult patients with active eosinophilic esophagitis: a randomized double-blind placebo-controlled phase 2 trial. Presented at: American College of Gastroenterology National Meeting","author":"Hirano","year":"2017"},{"key":"10.1016\/j.jaci.2018.05.018_bib22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2013.08.046","article-title":"Molecular diagnosis of eosinophilic esophagitis by gene expression profiling","volume":"145","author":"Wen","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cgh.2016.10.022","article-title":"Functional lumen imaging probe for the management of esophageal disorders: expert review from the Clinical Practice Updates Committee of the AGA Institute","volume":"15","author":"Hirano","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2018.05.018_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2010.09.037","article-title":"Mechanical properties of the esophagus in eosinophilic esophagitis","volume":"140","author":"Kwiatek","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cgh.2013.03.020","article-title":"Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis","volume":"11","author":"Nicodeme","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2018.05.018_bib26","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1038\/ctg.2017.47","article-title":"Improvement in esophageal distensibility in response to medical and diet therapy in eosinophilic esophagitis","volume":"8","author":"Carlson","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jaci.2018.05.018_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MPG.0b013e3182182ff8","article-title":"Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis","volume":"53","author":"Rubinstein","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2018.05.018_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev-pharmtox-010814-124407","article-title":"Novel targeted therapies for eosinophil-associated diseases and allergy","volume":"55","author":"Radonjic-Hoesli","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jaci.2018.05.018_bib29","first-page":"S1358","article-title":"Anti-siglec-8 antibody reduced eosinophil and mast cell infiltration in a mouse model of eosinophilic gastritis: a novel therapeutic approach for eosinophilic gastrointestinal diseases","volume":"154","author":"Youngblood","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib30","series-title":"Ak002, a first-in-class, humanized, non-fucosylated IGG1 siglec-8 antibody selectively depletes blood and tissue eosinophils","author":"Youngblood","year":"2018"},{"key":"10.1016\/j.jaci.2018.05.018_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng.547","article-title":"Common variants at 5q22 associate with pediatric eosinophilic esophagitis","volume":"42","author":"Rothenberg","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2018.05.018_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2010.04.037","article-title":"Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis","volume":"126","author":"Sherrill","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm.3281","article-title":"Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis","volume":"19","author":"Noti","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2018.05.018_bib34","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jaci.2014.12.1918","article-title":"Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma","volume":"135","author":"Smith","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib35","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2018.05.018_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2222.2006.02456.x","article-title":"The alpha4bbeta7-integrin is dynamically expressed on murine eosinophils and involved in eosinophil trafficking to the intestine","volume":"36","author":"Brandt","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.05.018_bib37","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1172\/JCI43586","article-title":"Epicutaneous challenge of orally immunized mice redirects antigen-specific gut-homing T cells to the skin","volume":"121","author":"Oyoshi","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.05.018_bib38","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.194.9.1243","article-title":"Intestinal\u00a0mast cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific homing","volume":"194","author":"Gurish","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.05.018_bib39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1521-4141(200103)31:3<860::AID-IMMU860>3.0.CO;2-9","article-title":"Blockade of either alpha-4 or beta-7 integrins selectively inhibits intestinal mast cell hyperplasia and worm expulsion in response to Nippostrongylus brasiliensis infection","volume":"31","author":"Issekutz","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1189\/jlb.1105643","article-title":"ICAM-1-dependent pathways regulate colonic eosinophilic inflammation","volume":"80","author":"Forbes","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2018.05.018_bib41","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/mi.2016.120","article-title":"Cadherin 26 is an alpha integrin-binding epithelial receptor regulated during allergic inflammation","volume":"10","author":"Caldwell","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2018.03.024","article-title":"Vedolizumab treatment may reduce steroid burden and improve histology in patients with eosinophilic gastroenteritis","author":"Kim","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2018.05.018_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.gtc.2014.02.006","article-title":"Allergic mechanisms in eosinophilic esophagitis","volume":"43","author":"Wechsler","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaci.2018.05.018_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/all.12542","article-title":"Eotaxin-3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteases","volume":"70","author":"Gela","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.05.018_bib45","doi-asserted-by":"crossref","first-page":"e0157376","DOI":"10.1371\/journal.pone.0157376","article-title":"JAK-STAT6 pathway inhibitors block eotaxin-3 secretion by epithelial cells and fibroblasts from esophageal eosinophilia patients: promising agents to improve inflammation and prevent fibrosis in EoE","volume":"11","author":"Cheng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2018.05.018_bib46","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1172\/JCI26679","article-title":"Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis","volume":"116","author":"Blanchard","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.05.018_bib47","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/j.1572-0241.2008.01937.x","article-title":"Treatment with topical steroids downregulates IL-5, eotaxin-1\/CCL11, and eotaxin-3\/CCL26 gene expression in eosinophilic esophagitis","volume":"103","author":"Lucendo","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2018.05.018_bib48","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ajg.2015.247","article-title":"Histological response to fluticasone propionate in patients with eosinophilic esophagitis is associated with improved functional esophageal mucosal integrity","volume":"110","author":"van Rhijn","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2018.05.018_bib49","doi-asserted-by":"crossref","first-page":"e50037","DOI":"10.1371\/journal.pone.0050037","article-title":"Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2018.05.018_bib50","doi-asserted-by":"crossref","first-page":"e101391","DOI":"10.1371\/journal.pone.0101391","article-title":"Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia","volume":"9","author":"Park","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2018.05.018_bib51","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MPG.0000000000001100","article-title":"Eosinophilic esophagitis-associated chemical and mechanical microenvironment shapes esophageal fibroblast behavior","volume":"63","author":"Muir","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2018.05.018_bib52","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2010.08.050","article-title":"Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction","volume":"126","author":"Aceves","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib53","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jaci.2014.04.004","article-title":"TGF-beta1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis","volume":"134","author":"Beppu","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib54","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1053\/j.gastro.2014.01.051","article-title":"T-helper 2 cytokines, transforming growth factor beta1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis","volume":"146","author":"Rieder","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib55","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/mi.2017.72","article-title":"TGF-beta1 alters esophageal epithelial barrier function by attenuation of claudin-7 in eosinophilic esophagitis","volume":"11","author":"Nguyen","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib56","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2016.02.028","article-title":"TGF-beta1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis","volume":"138","author":"Rawson","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1155\/2012\/628268","article-title":"Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats","volume":"26","author":"Wengrower","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jaci.2018.05.018_bib58","first-page":"79","article-title":"Understanding asthma pathophysiology","volume":"24","author":"Fireman","year":"2003","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2018.05.018_bib59","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.cgh.2017.05.048","article-title":"Efficacy of a 4-food elimination diet for children with eosinophilic esophagitis","volume":"15","author":"Kagalwalla","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2018.05.018_bib60","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/cea.12776","article-title":"IgE-associated food allergy alters the presentation of paediatric eosinophilic esophagitis","volume":"46","author":"Pelz","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.05.018_bib61","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaip.2016.11.020","article-title":"The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy","volume":"5","author":"Hill","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2018.05.018_bib62","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1189\/jlb.1106653","article-title":"Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice","volume":"81","author":"Mishra","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2018.05.018_bib63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/gut.2009.178020","article-title":"Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis","volume":"59","author":"Vicario","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2018.05.018_bib64","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-018-8671-6","article-title":"Does aeroallergen sensitization cause or contribute to eosinophilic esophagitis?","author":"Guajardo","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib65","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.anai.2016.08.008","article-title":"Role of food and aeroallergen sensitization in eosinophilic esophagitis in adults","volume":"117","author":"Olson","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib66","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.gastro.2014.05.036","article-title":"Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE","volume":"147","author":"Clayton","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib67","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaci.2007.06.015","article-title":"Anti-IgE treatment of eosinophil-associated gastrointestinal disorders","volume":"120","author":"Foroughi","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib68","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1159\/000331326","article-title":"Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy","volume":"3","author":"Johnsson","year":"2011","journal-title":"J Innate Immun"},{"key":"10.1016\/j.jaci.2018.05.018_bib69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/jpet.111.187203","article-title":"Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils","volume":"340","author":"Pettipher","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2018.05.018_bib70","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.4049\/jimmunol.177.4.2621","article-title":"Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor","volume":"177","author":"Satoh","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib71","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4049\/jimmunol.180.1.541","article-title":"Cyclooxygenase-2\/prostaglandin D2\/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation","volume":"180","author":"Shiraishi","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib72","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/all.12096","article-title":"Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis","volume":"68","author":"Straumann","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.05.018_bib73","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/gast.1996.v110.pm8608886","article-title":"Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis","volume":"110","author":"Desreumaux","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib74","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1067\/mai.2001.119917","article-title":"Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response","volume":"108","author":"Straumann","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib75","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.anai.2017.11.006","article-title":"Elevated expression of activated TH2 cells and milk-specific TH2 cells in milk-induced eosinophilic esophagitis","volume":"120","author":"Cianferoni","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib76","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/01.MIB.0000172557.39767.53","article-title":"Cytokine expression in healthy and inflamed mucosa: probing the role of eosinophils in the digestive tract","volume":"11","author":"Straumann","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2018.05.018_bib77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.mpg.0000188740.38757.d2","article-title":"Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis","volume":"42","author":"Gupta","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2018.05.018_bib78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MPG.0b013e318043c097","article-title":"Interplay of adaptive th2 immunity with eotaxin-3\/c-C chemokine receptor 3 in eosinophilic esophagitis","volume":"45","author":"Bullock","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2018.05.018_bib79","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2014.07.026","article-title":"Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome","volume":"134","author":"Caldwell","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib80","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jaci.2009.09.048","article-title":"Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(\u2212) T(H)2 responses","volume":"124","author":"Prussin","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2012-303631","article-title":"Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis","volume":"63","author":"Masterson","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2018.05.018_bib82","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/j.gastro.2007.10.002","article-title":"Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia","volume":"134","author":"Mishra","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib83","doi-asserted-by":"crossref","first-page":"G1347","DOI":"10.1152\/ajpgi.00013.2012","article-title":"Esophageal functional impairments in experimental eosinophilic esophagitis","volume":"302","author":"Mavi","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jaci.2018.05.018_bib84","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.4049\/jimmunol.1400732","article-title":"IL-5 triggers a cooperative cytokine network that promotes eosinophil precursor maturation","volume":"193","author":"Fulkerson","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib85","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaci.2015.05.048","article-title":"Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis","volume":"136","author":"Doherty","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib86","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","article-title":"Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis","volume":"118","author":"Stein","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2018.05.018_bib88","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa'ad","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib89","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib90","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1517\/14712598.2012.642359","article-title":"Benralizumab\u2013a humanized mAb to IL-5Ralpha with enhanced antibody-dependent cell-mediated cytotoxicity\u2013a novel approach for the treatment of asthma","volume":"12","author":"Ghazi","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jaci.2018.05.018_bib91","doi-asserted-by":"crossref","first-page":"AB196","DOI":"10.1016\/j.jaci.2017.12.622","article-title":"Benralizumab (anti-IL5Ra) depletes gut tissue eosinophilia and improves symptoms in hypereosionphilic syndrome with gastrointestinal involvement","volume":"141","author":"Kuang","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib92","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1007\/s10620-005-9048-2","article-title":"Allergen-specific in\u00a0vitro cytokine production in adult patients with eosinophilic esophagitis","volume":"51","author":"Yamazaki","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2018.05.018_bib93","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2007.10.024","article-title":"IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids","volume":"120","author":"Blanchard","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib94","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/gutjnl-2012-302250","article-title":"Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD","volume":"62","author":"Cheng","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2018.05.018_bib95","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.gastro.2003.07.007","article-title":"Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism","volume":"125","author":"Mishra","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2018.05.018_bib96","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/mi.2008.15","article-title":"Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses","volume":"1","author":"Blanchard","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib97","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/mi.2013.90","article-title":"Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis","volume":"7","author":"Sherrill","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib98","doi-asserted-by":"crossref","first-page":"e86355","DOI":"10.1172\/jci.insight.86355","article-title":"Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment","volume":"1","author":"Davis","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2018.05.018_bib99","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/mi.2015.98","article-title":"LRRC31 is induced by IL-13 and regulates kallikrein expression and barrier function in the esophageal epithelium","volume":"9","author":"D'Mello","year":"2016","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib100","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96789","article-title":"Synaptopodin is upregulated by IL-13 in eosinophilic esophagitis and regulates esophageal epithelial cell motility and barrier integrity","volume":"2","author":"Rochman","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2018.05.018_bib101","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.1000471","article-title":"IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway","volume":"185","author":"Zuo","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib102","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/gutjnl-2015-310341","article-title":"Autophagy mediates epithelial cytoprotection in eosinophilic oesophagitis","volume":"66","author":"Whelan","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2018.05.018_bib103","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1073\/pnas.90.8.3730","article-title":"Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells","volume":"90","author":"Punnonen","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.05.018_bib104","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2014.07.049","article-title":"Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis","volume":"135","author":"Rothenberg","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib105","author":"Dellon","year":"2016"},{"key":"10.1016\/j.jaci.2018.05.018_bib106","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaci.2010.10.039","article-title":"A striking local esophageal cytokine expression profile in eosinophilic esophagitis","volume":"127","author":"Blanchard","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.05.018_bib107","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jaci.2017.09.046","article-title":"Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci","volume":"141","author":"Martin","year":"2018","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918307802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918307802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:10:47Z","timestamp":1758791447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918307802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0091674918307802"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.05.018","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological therapies for eosinophilic gastrointestinal diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}